Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Minarini

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|April 19, 2002
Structure-activity relationships of methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. 2. Role of polymethylene chain lengths separating amine functions and of substituents on the terminal nitrogen atomsMichela Rosini, M Gabriele Bixel, Gabriella Marucci, et al.
Journal of Medicinal Chemistry|October 28, 2017
Pharmacophore Hybridization To Discover Novel Topoisomerase II Poisons with Promising Antiproliferative ActivityJose Antonio Ortega, Laura Riccardi, Elirosa Minniti, et al.
European Journal of Medicinal Chemistry|October 22, 2013
Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidasesEmanuela Bonaiuto, Andrea Milelli, Giorgio Cozza, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2011
Multitargeted drugs discovery: balancing anti-amyloid and anticholinesterase capacity in a single chemical entityMaria Laura Bolognesi, Manuela Bartolini, Andrea Tarozzi, et al.
Chemico-Biological Interactions|July 7, 2009
Cytotoxicity of methoctramine and methoctramine-related polyaminesMaddalena Zini, Catherine L Passariello, Davide Gottardi, et al.
Chemmedchem|October 27, 2015
Nature-Inspired Multifunctional Ligands: Focusing on Amyloid-Based Molecular Mechanisms of Alzheimer's DiseaseElena Simoni, Melania M Serafini, Manuela Bartolini, et al.
ACS Medicinal Chemistry Letters|November 17, 2022
Inhibition of β-Amyloid Aggregation in Alzheimer's Disease: The Key Role of (Pro)electrophilic WarheadsFilippo Basagni, Marina Naldi, Tiziana Ginex, et al.
European Journal of Medicinal Chemistry|May 3, 2016
Combined inhibition of the EGFR/AKT pathways by a novel conjugate of quinazoline with isothiocyanateAndrea Tarozzi, Chiara Marchetti, Benedetta Nicolini, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 5, 2019
Exploring the activity of polyamine analogues on polyamine and spermine oxidase: methoctramine, a potent and selective inhibitor of polyamine oxidaseMaria Luisa Di Paolo, Manuela Cervelli, Paolo Mariottini, et al.
Chemical Communications (Cambridge, England)|August 4, 2015
An optimized polyamine moiety boosts the potency of human type II topoisomerase poisons as quantified by comparative analysis centered on the clinical candidate F14512Giulia Palermo, Elirosa Minniti, Maria Laura Greco, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|April 19, 2002
Structure-activity relationships of methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. 2. Role of polymethylene chain lengths separating amine functions and of substituents on the terminal nitrogen atomsMichela Rosini, M Gabriele Bixel, Gabriella Marucci, et al.
Journal of Medicinal Chemistry|October 28, 2017
Pharmacophore Hybridization To Discover Novel Topoisomerase II Poisons with Promising Antiproliferative ActivityJose Antonio Ortega, Laura Riccardi, Elirosa Minniti, et al.
European Journal of Medicinal Chemistry|October 22, 2013
Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidasesEmanuela Bonaiuto, Andrea Milelli, Giorgio Cozza, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2011
Multitargeted drugs discovery: balancing anti-amyloid and anticholinesterase capacity in a single chemical entityMaria Laura Bolognesi, Manuela Bartolini, Andrea Tarozzi, et al.
Chemico-Biological Interactions|July 7, 2009
Cytotoxicity of methoctramine and methoctramine-related polyaminesMaddalena Zini, Catherine L Passariello, Davide Gottardi, et al.
Chemmedchem|October 27, 2015
Nature-Inspired Multifunctional Ligands: Focusing on Amyloid-Based Molecular Mechanisms of Alzheimer's DiseaseElena Simoni, Melania M Serafini, Manuela Bartolini, et al.
ACS Medicinal Chemistry Letters|November 17, 2022
Inhibition of β-Amyloid Aggregation in Alzheimer's Disease: The Key Role of (Pro)electrophilic WarheadsFilippo Basagni, Marina Naldi, Tiziana Ginex, et al.
European Journal of Medicinal Chemistry|May 3, 2016
Combined inhibition of the EGFR/AKT pathways by a novel conjugate of quinazoline with isothiocyanateAndrea Tarozzi, Chiara Marchetti, Benedetta Nicolini, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 5, 2019
Exploring the activity of polyamine analogues on polyamine and spermine oxidase: methoctramine, a potent and selective inhibitor of polyamine oxidaseMaria Luisa Di Paolo, Manuela Cervelli, Paolo Mariottini, et al.
Chemical Communications (Cambridge, England)|August 4, 2015
An optimized polyamine moiety boosts the potency of human type II topoisomerase poisons as quantified by comparative analysis centered on the clinical candidate F14512Giulia Palermo, Elirosa Minniti, Maria Laura Greco, et al.
Pageof 8